Honduras vs Oman: Access to anti-retroviral drugs, female
Honduras
76.0%
in 2024
Oman
76.0%
in 2024
Honduras rank
64th
Oman rank
64th
Access to anti-retroviral drugs, female over time
- Honduras
- Oman
How they compare
Honduras currently reports 76.0% against 76.0% in Oman, a difference of 0.0%.
The two have swapped places 10 times across 25 shared years of data; in 2000 it was Oman ahead.
Honduras ranks 64th and Oman ranks 64th of 141 countries.
Across the 3 decades both report, Honduras averaged higher in 2 and Oman in 1.
Head to head by decade
| Decade | Honduras | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.1% | 18.3% | 4.2% | Oman |
| 2010s | 55.7% | 55.5% | 0.2% | Honduras |
| 2020s | 71.6% | 71.0% | 0.6% | Honduras |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Honduras or Oman?
- Honduras, at 76.0% against 76.0% in Oman as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Honduras and Oman?
- 0.0%, with Honduras ahead.
- How many years of comparable data are there for Honduras and Oman?
- 25 years are reported by both, from 2000 to 2024.
- How do Honduras and Oman rank globally for access to anti-retroviral drugs, female?
- Honduras ranks 64th and Oman ranks 64th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.